Pertinax provides sustained, controlled antimicrobial protection for medical devices, biomaterials and in topical formulations.
Pertinax Pharma are supported by an experienced management team and a highly skilled and versatile team of scientists.
Get in touch to learn more about our technology and to discuss how Pertinax might be used in your products.
Get In Touch
About Pertinax Pharma
Pertinax formed in 2015, as a spin-out from the University of Bristol. The technology was initially developed in the laboratory of Dr Michele Barbour, CEO. Michele is supported by an experienced management team and a dynamic and dedicated team of scientists.
Find out the latest news and information from Pertinax.
We are excited to announce that we are looking for a graduate microbiologist to join our growing team. This new role will build capacity in microbiology, one of our core activities. The successful candidate will be primarily laboratory … Read More about Pertinax are recruiting!
We are proud to report that our iCASE PhD student Liam Cundy has been selected to give an oral presentation of his work at the annual meeting of the British Cattle Veterinary Association in October. Liam, a qualified vet, is working … Read More about Development of a Pertinax spray for treating foot disease in cows: Liam Cundy to present at British Cattle Veterinary Association
A team of academics from Oxford Brookes’ Centre for Diversity Policy Research and Practice have conducted a study of representation of women in spin-outs, from founding, to board representation, CEO and other leadership positions, and other … Read More about Michele speaks at “Women in Spinouts” Event, Oxford Brookes University